Literature DB >> 27258652

Compartmentation of metabolites in regulating epigenome of cancer.

Zhiqiang Zhao1, Li Wang1,2, Lijun Di1.   

Abstract

Covalent modification of DNA and histones are important epigenetic events and the genome wide reshaping of epigenetic markers is common in cancer. The epigenetic markers are produced by enzymatic reactions and some of these reactions require the presence of metabolites as cofactors (termed Epigenetic Enzyme Required Metabolites, EERMs). Recent studies found that the abundance of these EERMs correlates with epigenetic enzyme activities. Also, the subcellular compartmentation, especially the nuclear localization of these EERMs may play a role in regulating the activities of epigenetic enzymes. Moreover, gene specific recruitment of enzymes which produce the EERMs in the proximity of the epigenetic modification events accompanying the gene expression regulation, were proposed. Therefore, it is of importance to summarize these findings of the EERMs in regulating the epigenetic modifications at both DNA and histone levels, and to understand how EERMs contribute to cancer development by addressing their global versus local distribution.

Entities:  

Keywords:  DNA methylation; EERM; Epigenetics; cancer cell metabolism; gene regulation; histone modification; metabolites

Year:  2016        PMID: 27258652      PMCID: PMC5072407          DOI: 10.2119/molmed.2016.00051

Source DB:  PubMed          Journal:  Mol Med        ISSN: 1076-1551            Impact factor:   6.354


  148 in total

1.  Linking DNA-binding proteins to their recognition sequences by using protein microarrays.

Authors:  Su-Wen Ho; Ghil Jona; Christina T L Chen; Mark Johnston; Michael Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-19       Impact factor: 11.205

2.  Oxidation of alpha-ketoglutarate is required for reductive carboxylation in cancer cells with mitochondrial defects.

Authors:  Andrew R Mullen; Zeping Hu; Xiaolei Shi; Lei Jiang; Lindsey K Boroughs; Zoltan Kovacs; Richard Boriack; Dinesh Rakheja; Lucas B Sullivan; W Marston Linehan; Navdeep S Chandel; Ralph J DeBerardinis
Journal:  Cell Rep       Date:  2014-05-22       Impact factor: 9.423

3.  Beta-N-acetylglucosamine (O-GlcNAc) is part of the histone code.

Authors:  Kaoru Sakabe; Zihao Wang; Gerald W Hart
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-02       Impact factor: 11.205

Review 4.  DNA methylation and gene silencing in cancer.

Authors:  Stephen B Baylin
Journal:  Nat Clin Pract Oncol       Date:  2005-12

5.  Low-dose methotrexate inhibits methionine S-adenosyltransferase in vitro and in vivo.

Authors:  Yi-Cheng Wang; En-Pei Isabel Chiang
Journal:  Mol Med       Date:  2012-05-09       Impact factor: 6.354

6.  Suppression of oxidative stress by β-hydroxybutyrate, an endogenous histone deacetylase inhibitor.

Authors:  Tadahiro Shimazu; Matthew D Hirschey; John Newman; Wenjuan He; Kotaro Shirakawa; Natacha Le Moan; Carrie A Grueter; Hyungwook Lim; Laura R Saunders; Robert D Stevens; Christopher B Newgard; Robert V Farese; Rafael de Cabo; Scott Ulrich; Katerina Akassoglou; Eric Verdin
Journal:  Science       Date:  2012-12-06       Impact factor: 47.728

Review 7.  Sorting out functions of sirtuins in cancer.

Authors:  M Roth; W Y Chen
Journal:  Oncogene       Date:  2013-04-22       Impact factor: 9.867

8.  An inhibitor of mutant IDH1 delays growth and promotes differentiation of glioma cells.

Authors:  Dan Rohle; Janeta Popovici-Muller; Nicolaos Palaskas; Sevin Turcan; Christian Grommes; Carl Campos; Jennifer Tsoi; Owen Clark; Barbara Oldrini; Evangelia Komisopoulou; Kaiko Kunii; Alicia Pedraza; Stefanie Schalm; Lee Silverman; Alexandra Miller; Fang Wang; Hua Yang; Yue Chen; Andrew Kernytsky; Marc K Rosenblum; Wei Liu; Scott A Biller; Shinsan M Su; Cameron W Brennan; Timothy A Chan; Thomas G Graeber; Katharine E Yen; Ingo K Mellinghoff
Journal:  Science       Date:  2013-04-04       Impact factor: 47.728

9.  Acetyl-CoA synthetase 2 promotes acetate utilization and maintains cancer cell growth under metabolic stress.

Authors:  Zachary T Schug; Barrie Peck; Dylan T Jones; Qifeng Zhang; Shaun Grosskurth; Israt S Alam; Louise M Goodwin; Elizabeth Smethurst; Susan Mason; Karen Blyth; Lynn McGarry; Daniel James; Emma Shanks; Gabriela Kalna; Rebecca E Saunders; Ming Jiang; Michael Howell; Francois Lassailly; May Zaw Thin; Bradley Spencer-Dene; Gordon Stamp; Niels J F van den Broek; Gillian Mackay; Vinay Bulusu; Jurre J Kamphorst; Saverio Tardito; David Strachan; Adrian L Harris; Eric O Aboagye; Susan E Critchlow; Michael J O Wakelam; Almut Schulze; Eyal Gottlieb
Journal:  Cancer Cell       Date:  2015-01-12       Impact factor: 31.743

10.  Insight into S-adenosylmethionine biosynthesis from the crystal structures of the human methionine adenosyltransferase catalytic and regulatory subunits.

Authors:  Naeem Shafqat; Joao R C Muniz; Ewa S Pilka; Evangelos Papagrigoriou; Frank von Delft; Udo Oppermann; Wyatt W Yue
Journal:  Biochem J       Date:  2013-05-15       Impact factor: 3.857

View more
  10 in total

1.  VDAC1 is a molecular target in glioblastoma, with its depletion leading to reprogrammed metabolism and reversed oncogenic properties.

Authors:  Tasleem Arif; Yakov Krelin; Itay Nakdimon; Daniel Benharroch; Avijit Paul; Daniela Dadon-Klein; Varda Shoshan-Barmatz
Journal:  Neuro Oncol       Date:  2017-07-01       Impact factor: 12.300

2.  Mitochondrial VDAC1-based peptides: Attacking oncogenic properties in glioblastoma.

Authors:  Anna Shteinfer-Kuzmine; Tasleem Arif; Yakov Krelin; Shambhoo Sharan Tripathi; Avijit Paul; Varda Shoshan-Barmatz
Journal:  Oncotarget       Date:  2017-05-09

3.  Genome-wide methylome and chromatin interactome identify abnormal enhancer to be risk factor of breast cancer.

Authors:  Yuan Wang; Da-Peng Hao; Jing-Jing Li; Li Wang; Li-Jun Di
Journal:  Oncotarget       Date:  2017-07-04

Review 4.  Metabolic Dysregulations and Epigenetics: A Bidirectional Interplay that Drives Tumor Progression.

Authors:  Fabiana Crispo; Valentina Condelli; Silvia Lepore; Tiziana Notarangelo; Alessandro Sgambato; Franca Esposito; Francesca Maddalena; Matteo Landriscina
Journal:  Cells       Date:  2019-07-30       Impact factor: 6.600

5.  Methylome Variation Predicts Exemestane Resistance in Advanced ER+ Breast Cancer.

Authors:  Xiao-Ran Liu; Ru-Yan Zhang; Hao Gong; Hope S Rugo; Ling-Bo Chen; Yuan Fu; Jian-Wei Che; Jian Tie; Bin Shao; Feng-Ling Wan; Wei-Yao Kong; Guo-Hong Song; Han-Fang Jiang; Guo-Bing Xu; Hui-Ping Li
Journal:  Technol Cancer Res Treat       Date:  2020 Jan-Dec

Review 6.  Towards Multiplexed and Multimodal Biosensor Platforms in Real-Time Monitoring of Metabolic Disorders.

Authors:  Sung Sik Chu; Hung Anh Nguyen; Jimmy Zhang; Shawana Tabassum; Hung Cao
Journal:  Sensors (Basel)       Date:  2022-07-12       Impact factor: 3.847

7.  Molecular link between glucose and glutamine consumption in cancer cells mediated by CtBP and SIRT4.

Authors:  Li Wang; Jing-Jing Li; Li-Yu Guo; Peipei Li; Zhiqiang Zhao; Haisheng Zhou; Li-Jun Di
Journal:  Oncogenesis       Date:  2018-03-13       Impact factor: 7.485

8.  The Mitochondrial Protein VDAC1 at the Crossroads of Cancer Cell Metabolism: The Epigenetic Link.

Authors:  Zohar Amsalem; Tasleem Arif; Anna Shteinfer-Kuzmine; Vered Chalifa-Caspi; Varda Shoshan-Barmatz
Journal:  Cancers (Basel)       Date:  2020-04-22       Impact factor: 6.639

9.  Rewiring of Cancer Cell Metabolism by Mitochondrial VDAC1 Depletion Results in Time-Dependent Tumor Reprogramming: Glioblastoma as a Proof of Concept.

Authors:  Tasleem Arif; Oriel Stern; Srinivas Pittala; Vered Chalifa-Caspi; Varda Shoshan-Barmatz
Journal:  Cells       Date:  2019-10-28       Impact factor: 7.666

Review 10.  VDAC1 at the Intersection of Cell Metabolism, Apoptosis, and Diseases.

Authors:  Varda Shoshan-Barmatz; Anna Shteinfer-Kuzmine; Ankit Verma
Journal:  Biomolecules       Date:  2020-10-26
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.